Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-08-10

Clinical Trial Update: Allergenic Effect of Ambrosia in Israel

View source ↗

Summary

This ClinicalTrials.gov update describes a study on the allergenic effects of Ambrosia (ragweed) in Israel, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Allergy, Ambrosia | Status: UNKNOWN